Variant report
Variant | nsv975828 |
---|---|
Chromosome Location | chr11:5192464-5209037 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:44)
- CpG islands (count:0)
- Chromatin interactive region (count:8)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:44 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ARID3A | chr11:5193260-5193372 | K562 | blood: | n/a | n/a |
2 | ARID3A | chr11:5194443-5194536 | K562 | blood: | n/a | n/a |
3 | ATF1 | chr11:5199045-5199305 | K562 | blood: | n/a | n/a |
4 | BHLHE40 | chr11:5193299-5193453 | K562 | blood: | n/a | n/a |
5 | CCNT2 | chr11:5206078-5206231 | K562 | blood: | n/a | n/a |
6 | CEBPB | chr11:5199668-5200048 | K562 | blood: | n/a | n/a |
7 | CEBPB | chr11:5199688-5200003 | A549 | lung: | n/a | n/a |
8 | CEBPB | chr11:5199691-5200054 | IMR90 | lung: | n/a | n/a |
9 | CEBPB | chr11:5199688-5200067 | K562 | blood: | n/a | n/a |
10 | CEBPB | chr11:5199690-5200049 | HepG2 | liver: | n/a | n/a |
11 | CHD2 | chr11:5195669-5195693 | GM12878 | blood: | n/a | n/a |
12 | E2F4 | chr11:5207722-5207994 | MCF10A-Er-Src | breast: | n/a | n/a |
13 | E2F4 | chr11:5195343-5195706 | MCF10A-Er-Src | breast: | n/a | n/a |
14 | ELF1 | chr11:5199501-5199828 | K562 | blood: | n/a | chr11:5199662-5199675 |
15 | EP300 | chr11:5193277-5193345 | K562 | blood: | n/a | n/a |
16 | EP300 | chr11:5193168-5193440 | K562 | blood: | n/a | n/a |
17 | FAM48A | chr11:5205800-5205961 | GM12878 | blood: | n/a | n/a |
18 | GATA2 | chr11:5193089-5193482 | K562 | blood: | n/a | chr11:5193396-5193408 |
19 | IRF1 | chr11:5195603-5195739 | K562 | blood: | n/a | n/a |
20 | IRF3 | chr11:5195651-5195661 | GM12878 | blood: | n/a | n/a |
21 | JUN | chr11:5194475-5194479 | K562 | blood: | n/a | n/a |
22 | MYC | chr11:5199668-5199791 | K562 | blood: | n/a | n/a |
23 | MYC | chr11:5193269-5193405 | K562 | blood: | n/a | n/a |
24 | NFYB | chr11:5208248-5208523 | K562 | blood: | n/a | chr11:5208376-5208386 |
25 | NR2F2 | chr11:5193109-5193474 | K562 | blood: | n/a | n/a |
26 | NR2F2 | chr11:5192960-5193507 | K562 | blood: | n/a | n/a |
27 | POLR2A | chr11:5192931-5193030 | MCF10A-Er-Src | breast: | n/a | n/a |
28 | POLR2A | chr11:5195116-5195176 | MCF10A-Er-Src | breast: | n/a | n/a |
29 | POLR2A | chr11:5193131-5193405 | K562 | blood: | n/a | n/a |
30 | RCOR1 | chr11:5193156-5193450 | K562 | blood: | n/a | n/a |
31 | RCOR1 | chr11:5199612-5199798 | K562 | blood: | n/a | n/a |
32 | RCOR1 | chr11:5195428-5195650 | K562 | blood: | n/a | n/a |
33 | RFX5 | chr11:5208996-5209108 | K562 | blood: | n/a | n/a |
34 | SPI1 | chr11:5202934-5203057 | K562 | blood: | n/a | n/a |
35 | SPI1 | chr11:5202912-5203079 | GM12891 | blood: | n/a | n/a |
36 | SPI1 | chr11:5202591-5203385 | GM12878 | blood: | n/a | n/a |
37 | TAL1 | chr11:5193068-5193487 | K562 | blood: | n/a | chr11:5193212-5193221 |
38 | TBL1XR1 | chr11:5193247-5193421 | K562 | blood: | n/a | n/a |
39 | TEAD4 | chr11:5193087-5193521 | K562 | blood: | n/a | n/a |
40 | TEAD4 | chr11:5193077-5193496 | K562 | blood: | n/a | n/a |
41 | UBTF | chr11:5199658-5199779 | K562 | blood: | n/a | n/a |
42 | ZC3H11A | chr11:5199786-5199861 | K562 | blood: | n/a | n/a |
43 | ZNF143 | chr11:5192655-5192677 | K562 | blood: | n/a | n/a |
44 | ZNF274 | chr11:5192595-5193989 | K562 | blood: | n/a | n/a |
No data |
(count:8 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr11:5208760..5213541-chr11:5217325..5221735,4 | K562 | blood: | |
2 | chr11:5192167..5196032-chr11:5198178..5201494,6 | K562 | blood: | |
3 | chr11:5174124..5177497-chr11:5196224..5198159,3 | K562 | blood: | |
4 | chr11:5191942..5195830-chr11:5198178..5202032,4 | K562 | blood: | |
5 | chr11:5191942..5195830-chr11:5198178..5202032,4 | K562 | blood: | |
6 | chr11:5192167..5196032-chr11:5198178..5201494,6 | K562 | blood: | |
7 | chr11:5188106..5190567-chr11:5193129..5195928,3 | K562 | blood: | |
8 | chr11:5151076..5153190-chr11:5193820..5196178,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
OR52Z1 | TF binding region |
OR51A1P | TF binding region |
OR52A1 | TF binding region |
ENSG00000176748 | chromatin interactions |
ENSG00000176752 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs546692173 | chr11:5192483-5192484 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs573891785 | chr11:5192502-5192503 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs386750121 | chr11:5192520-5192521 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs74816008 | chr11:5192521-5192522 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs555265097 | chr11:5192526-5192527 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs576626190 | chr11:5192530-5192531 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs373622721 | chr11:5192535-5192536 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs80217518 | chr11:5192557-5192558 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs115632309 | chr11:5192566-5192567 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs534778473 | chr11:5192569-5192570 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs545706170 | chr11:5192584-5192585 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs7479400 | chr11:5192596-5192597 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs541614850 | chr11:5192609-5192610 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
14 | rs538045106 | chr11:5192642-5192643 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
15 | rs180915236 | chr11:5192663-5192664 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
16 | rs79026050 | chr11:5192675-5192676 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
17 | rs73396899 | chr11:5192685-5192686 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs533824521 | chr11:5192702-5192703 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
19 | rs563893465 | chr11:5192728-5192729 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
20 | rs4910539 | chr11:5192729-5192730 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs546332045 | chr11:5192736-5192737 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
22 | rs184739345 | chr11:5192743-5192744 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
23 | rs561832948 | chr11:5192772-5192773 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
24 | rs529041440 | chr11:5192788-5192789 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
25 | rs374925995 | chr11:5192807-5192808 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
26 | rs142111368 | chr11:5192820-5192821 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
27 | rs189647224 | chr11:5192828-5192829 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
28 | rs147365694 | chr11:5192830-5192831 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
29 | rs181579829 | chr11:5192837-5192838 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
30 | rs368169740 | chr11:5192857-5192858 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
31 | rs75961031 | chr11:5192860-5192861 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
32 | rs73398606 | chr11:5192873-5192874 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs574588883 | chr11:5192896-5192897 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
34 | rs140928842 | chr11:5192909-5192910 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
35 | rs549673968 | chr11:5192961-5192962 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
36 | rs74051396 | chr11:5192963-5192964 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs73398609 | chr11:5192964-5192965 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs371854278 | chr11:5192976-5192977 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
39 | rs74234646 | chr11:5193035-5193036 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
40 | rs36046192 | chr11:5193072-5193073 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
41 | rs572710366 | chr11:5193092-5193093 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
42 | rs187068125 | chr11:5193143-5193144 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
43 | rs191664757 | chr11:5193153-5193154 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
44 | rs551197219 | chr11:5193180-5193181 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
45 | rs147963327 | chr11:5193204-5193205 | Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
46 | rs145764844 | chr11:5193264-5193265 | Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
47 | rs528976942 | chr11:5193281-5193282 | Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
48 | rs73398611 | chr11:5193282-5193283 | Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs73398612 | chr11:5193305-5193306 | Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs10768633 | chr11:5193338-5193339 | Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 19432969 | CNVD |
Alzheimer''s disease | 17576883 | CNVD |
Long-qt syndrome | 17576883 | CNVD |
Emphysema | 19352772 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Chordoma | 18071362 | CNVD |
Breast cancer | 16608533 | CNVD |
Cancer | 21183584 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Breast cancer | 17603634 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Wilms tumour | 21544195 | CNVD |
Parathyroid adenoma | 22454399 | CNVD |
Chordoma | 21602918 | CNVD |
Breast cancer | 21949216 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 19222835 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Beckwith-Wiedemann syndrome | 21518781 | CNVD |
Wilms tumour | 21518781 | CNVD |
Hepatoblastoma | 21518781 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Gastric cancer | 17908304 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Autism | 22495311 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Neuroblastoma | 21124317 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Lung cancer | 17086460 | CNVD |
Schizophrenia | 21399695 | CNVD |
Gastric cancer | 16891809 | CNVD |
Cancer | 17160897 | CNVD |
Multiple myeloma | 16616336 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21364760 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:5191600-5193200 | Enhancers | K562 | blood |
2 | chr11:5193200-5193600 | Flanking Active TSS | K562 | blood |
3 | chr11:5193600-5194000 | Enhancers | K562 | blood |
4 | chr11:5194000-5199000 | Weak transcription | K562 | blood |
5 | chr11:5199000-5200000 | Enhancers | K562 | blood |